子宮頸部ジストニアにおけるボツリヌム毒素に対する痛みの局所化と反応
Alexander S Wang1,2, Hanieh Agharazi2,3, Aetan Parmar4
1Movement Disorders Center, Department of Neurology, University Hospitals Cleveland Medical Center, Cleveland, OH, United States.
Dystonia (Lausanne, Switzerland)
|September 2, 2025
まとめ
ボトリヌム毒素は,頸部ジストニア (CD) の痛みを効果的に軽減します. 痛みは通常,後部頸筋で発生し,これらの領域の近くで注射は助けますが,最適な痛みの管理戦略のためにさらなる研究が必要です.
科学分野:
- 神経科学
- 痛みの治療
- 運動障害
背景:
- 子宮頸部ジストニア (CD) はしばしば痛みを引き起こし,患者の生活の質に影響します.
- ボトリヌム毒素はCDの主要な治療法で,鎮痛作用があることが知られている.
研究 の 目的:
- CD患者の痛みの位置を特徴付けるため
- ボトリヌム毒素治療後の痛みの軽減を予測する要因を特定する.
主な方法:
- ボトリヌム毒素を投与されたCD患者による観察研究.
- 疼痛の位置と強さは,調査と疼痛評価尺度を用いて,治療前と治療後2週間で評価された.
主要な成果:
- ほとんどの患者は後部頸筋の痛みを報告し,特に上部トラペシウスと上部肩骨の痛みを報告した.
- 患者の50%以上は,主痛部位の強度が少なくとも30%減少した.
- 治療後の痛みの位置は安定しており,注射部位の近接は痛みの改善と明らかに相関していない.
結論:
- ボトリヌム毒素はCDに関連する痛みに対して有効であることが確認されています.
- 典型的な痛みの部位は トラペシウスの上部,肩の上の部,筋です.
- ボトリヌム毒素の治療戦略を最適化するために,より大きな研究が必要である.
関連する概念動画
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
751
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
751
Skeletal Muscle Relaxants: Therapeutic Uses
612
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
612
Peripherally and Centrally Acting Muscle Relaxants: A Comparison
3.7K
Skeletal muscle relaxants can target the central nervous system [CNS] to reduce muscle tension or act directly at the neuromuscular junction to induce temporary paralysis. These two classes of muscle relaxants are called centrally acting muscle relaxants and peripherally acting muscle relaxants. They differ in their action, mechanism, administration route, and clinical uses.
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic...
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic...
3.7K
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
525
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Although all competitive neuromuscular blockers are designed...
525
Local Anesthetics: Differential Sensitivity of Nerve Fibers
929
Local anesthetics (LAs) block the sodium channels of nerve trunks, sensory nerve endings, and neuromuscular junctions. Although LAs can block all kinds of nerves, the sensitivity of nerve fibers differs according to nerve types and structures. LAs are known to block myelinated fibers faster than unmyelinated ones. Also, they block pain or sensory neurons at low concentrations without affecting the motor neurons involved in muscle contractions. This helps relieve labor pain without affecting the...
929
Classification of Skeletal Muscle Relaxants
2.7K
Skeletal muscle relaxants are a group of drugs that can reduce muscle stiffness and induce temporary paralysis to relieve pain. These agents can act centrally to reduce muscle tone or spasms in painful conditions such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), or spinal injuries; they are called antispasmodics or spasmolytics.
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
2.7K


